Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer.

Hareyama H, Ito K, Watanabe S, Hakoyama M, Uchida A, Oku K, Watanabe Y, Hayakashi Y, Hirayama E, Okuyama K.

Int J Gynecol Cancer. 2012 Nov;22(9):1577-84. doi: 10.1097/IGC.0b013e31826fd644.

PMID:
23060049
2.

Lymph node counts in endometrial cancer: expectations versus reality.

Euscher ED, Bassett R, Malpica A.

Am J Surg Pathol. 2011 Jun;35(6):913-8. doi: 10.1097/PAS.0b013e31821899be.

PMID:
21566518
3.

Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.

Altay A, Toptas T, Dogan S, Simsek T, Pestereli E.

Int J Gynecol Cancer. 2015 May;25(4):657-64. doi: 10.1097/IGC.0000000000000392.

PMID:
25647255
4.

Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.

Solmaz U, Mat E, Dereli ML, Turan V, Tosun G, Dogan A, Sanci M, Ozdemir IA, Pala EE.

Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:63-7. doi: 10.1016/j.ejogrb.2015.01.006. Epub 2015 Jan 23.

PMID:
25638600
5.

Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.

Sueoka K, Umayahara K, Abe A, Usami T, Yamamoto A, Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Takeshima N.

Int J Gynecol Cancer. 2015 Jan;25(1):81-6. doi: 10.1097/IGC.0000000000000268.

PMID:
25347094
6.

Can we omit para-aorta lymph node dissection in endometrial cancer?

Tanaka H, Sato H, Miura H, Sato N, Fujimoto T, Konishi Y, Takahashi O, Tanaka T.

Jpn J Clin Oncol. 2006 Sep;36(9):578-81. Epub 2006 Jul 26.

PMID:
16870694
7.

Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.

Ditto A, Martinelli F, Reato C, Kusamura S, Solima E, Fontanelli R, Haeusler E, Raspagliesi F.

Ann Surg Oncol. 2012 Nov;19(12):3849-55. doi: 10.1245/s10434-012-2439-7. Epub 2012 Jun 16.

PMID:
22707110
8.

Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer.

Mariani A, Webb MJ, Keeney GL, Podratz KC.

Gynecol Oncol. 2001 Apr;81(1):100-4.

PMID:
11277658
9.

[Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].

Wang ZQ, Zhang Y, Wang JL, Shen DH, Zhao X, Yao YY, Bai Y, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2011 Jun;46(6):435-40. Chinese.

PMID:
21781585
10.

Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?

Roger N, Zafrani Y, Uzan C, Gouy S, Rey A, Pautier P, Lhommé C, Duvillard P, Castaigne D, Morice P.

Ann Surg Oncol. 2008 Jan;15(1):333-8. Epub 2007 Oct 18.

PMID:
17943386
11.

Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.

Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.

Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.

PMID:
20683408
12.

Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.

Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC.

Gynecol Oncol. 2006 May;101(2):200-8. Epub 2006 Feb 28.

PMID:
16510174
13.

Pelvic and aortic lymph node metastasis in epithelial ovarian cancer.

Pereira A, Magrina JF, Rey V, Cortes M, Magtibay PM.

Gynecol Oncol. 2007 Jun;105(3):604-8. Epub 2007 Feb 23.

PMID:
17321572
14.

Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.

Menderes G, Azodi M, Schwartz P, Silasi DA.

Int J Gynecol Cancer. 2015 Jan;25(1):160-5. doi: 10.1097/IGC.0000000000000308.

PMID:
25386859
15.

Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer.

Fotopoulou C, El-Balat A, du Bois A, Sehouli J, Harter P, Muallem MZ, Krätschell RW, Traut A, Heitz F.

Arch Gynecol Obstet. 2015 Dec;292(6):1321-7. doi: 10.1007/s00404-015-3746-6. Epub 2015 May 20.

PMID:
25990476
16.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
17.

Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.

Fotopoulou C, Savvatis K, Kraetschell R, Schefold JC, Lichtenegger W, Sehouli J.

Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):199-203. doi: 10.1016/j.ejogrb.2009.12.021. Epub 2010 Jan 22.

PMID:
20096987
18.

Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.

Bachmann C, Krämer B, Brucker SY, Stäbler A, Fend F, Wallwiener D, Grischke EM, Rothmund R.

Anticancer Res. 2014 Nov;34(11):6735-8.

PMID:
25368283
19.

Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.

Takeshima N, Hirai Y, Umayahara K, Fujiwara K, Takizawa K, Hasumi K.

Gynecol Oncol. 2005 Nov;99(2):427-31. Epub 2005 Aug 19.

PMID:
16112718
20.

Lymphatic spread among women with primary peritoneal carcinoma.

Eltabbakh GH, Mount SL.

J Surg Oncol. 2002 Nov;81(3):126-31.

PMID:
12407724

Supplemental Content

Support Center